Price to Sales ratio Analysis of Dr. Reddy’s Laboratories Ltd. - Deep Dive
WARN : Please note that some of the values may not be in base currency

Latest FY PS
Period Ending - Mar-24

0.0410


Excellent PS
Period Ending - Mar-23
0.0464

Excellent PS
Growth
-11.60 %
Trailing Twelve Months PS
Period Ending - Mar-24

0.0410


Excellent PS
PS Analysis of Dr. Reddy’s Laboratories Ltd.
P/S Ratio 0.0410 of Dr. Reddy’s Laboratories Ltd. indicates that stock price is low compared to sales of the company and may be undervalued.
PS Ratio of RDY has fallen by -11.60 % Compared to previous Financial Year.
PS Ratio with value of 0.065 was highest in Year Mar-20 in last Five Years.
PS Ratio of RDY trending down for at least three Years.
Latest PS Ratio with value of 0.0410 is lower than Average PS of 0.053 in last five years.
Other PS Related Info of RDY that may interest you.
Dr. Reddy’s Laboratories Ltd. Overview
CodePricePrevious PricePrice ChangeSector
RDY68.6869.86 1.69 % Drug Manufacturers-Specialty & Generic
Fundamental AnalysisTechnical Analysis
Defination of Price to Sales
The Price to Sales Ratio indicates how much investors are willing to pay for each rupee of sales generated by a company. Price-to-Sales Ratio is used to determine whether a stock is currently profitable or less profitable, which is helpful for better investment decisions.   more ..
Price to Sales Formula

PS Related Ratios
PriceToBookRatioPriceToEarningRatioAssetTurnoverRatio

Tsr Value Index
Excellent Value
FY - Historical Price to Sales of Dr. Reddy’s Laboratories Ltd.
PeriodMar-24Mar-23Mar-22Mar-21Mar-20Mar-19Mar-18
PS0.04100.04640.0530.0600.0650.0740.080
Change-11.60 %-12.93 %-11.50 %-7.84 %-11.94 %-7.69 %-1.33 %
You are view first 7 Records. Log in to view all 25 in Premium view
FY Chart of Price to Sales of Dr. Reddy’s Laboratories Ltd.


Note : All Data Generated at the End of Trading Hours (EOD Data)